Search

With increased vaccination rates, the development of effective treatments and the introduction of at-home rapid tests, the approach to managing COVID-19 cases has evolved. Doctors Manitoba has created this article to assist physicians to support patients who may need COVID-19 testing, diagnosis, and treatment.

COVID-19 Testing

Effective April 15, all provincial COVID-19 testing sites are closing. While most COVID-19 testing is now happening at home using self-administered rapid antigen tests (RATs), some patients will continue to require a test administered by a physician or health care professional, often in primary care settings. For further background on the transition to primary care-based testing, see this memo from Public Health and this memo from Shared Health.

Physicians are encouraged to review the following resources, including clinical guidance, test supply ordering, and remuneration guidance.

To get your clinic is set up, you should use the resources below to ensure:

  • Reception staff can effectively screen and direct patients appropriately
  • You have sufficient rapid tests and PCR test supplies on site (available at no charge)
  • Appropriate PPE is available for physicians/​staff
  • A protocol is in place to notify patients of positive test results, especially when time-sensitive COVID-19 treatments may be necessary

Watch our webinar on changes to COVID-19 testing and treatment in primary care.

Clinical Guidance Resources

With the transfer of testing to primary care Shared Health has issued new clinical guidance in relation to screening, testing and treatment of COVID-19 we recommend you review that guidance.

Most patients should be able to use a self-administered RAT at home to test for COVID-19, with physicians offering guidance on isolation and symptom monitoring. Generally, the only patients who need a COVID-19 test from a physician or other health care provider are those who have symptoms and for whom knowing the test result would inform the medical management or treatment decisions, or if they have serious symptoms or live in a higher risk setting. At times, Public Health may also direct individuals to be tested. It may also include children, individuals with developmental or medical issues that make conducting a test difficult.

Key resources for physicians include:

For PCR test results, patients should be advised to check on their own through the Shared Health Online Portal or by calling Health Links-Info Santé. Patients who test positive should be contacted by the physician’s office in a timely way to ensure they understand isolation guidance, symptom monitoring, and to ensure they are referred for time-sensitive treatment, if eligible (see treatment and remuneration guidance section below).

Patient Resources

  • Rapid Tests: For pick-up locations and instructions, patients can visit this government website (Provincial Government) 
  • COVID-19 Public Health Factsheet including isolation guidance for patients (Manitoba Public Health)
  • Handout Shared Health COVID Results Portal info English & French (Shared Health)
  • Eligibility for COVID-19 Treatment information for patients (Manitoba Health)

Test Supply Ordering

Ensure your clinic has sufficient testing supplies on site.
Rapid Tests:

PCR supplies

Remuneration Guidance

Doctors Manitoba has been successful in negotiating new tariffs for the administration of the Rapid Tests and PCR tests by physicians. 

NOTE: tariff numbers have not yet bee issued for these new tariff. Doctors Manitoba will be sure to communicate once a number has been assigned. 

Tariffs

9211 COVID-19 Rapid Antigen Detection Test (RAT) — $15.00
9212
COVID19 Nasopharyngeal Swab for Polymerase Chain Reaction (PCR) test — $15.00

These tariffs have been negotiated at a higher rate than other swab tests in recognition of the PPE requirements of physicians offices in doing this work. Also note that testing supplies are provided by the province at no charge, so the tariff does not also cover testing supply costs.

The tariff may be billed in addition to a visit tariff where clinically indicated. Given the current clinical guidelines, and availability of RATs to the public, it is anticipated that a visit will be appropriate for most patients.

Shared Health guidance contemplates limited scenarios in which both a RAT and PCR may be administer on the same day. In this instance, you may bill both tariffs on the same day.

Where a PCR test result is returned positive and the physician contacts the patient to discuss the result, ensure they understand isolation guidance, symptom monitoring, and to ensure they are referred for time-sensitive treatment, if eligible. The physician may bill a visit (virtual or in person, as applicable). 

This tariff is retroactive to March 1, 2022. If you have been assisting patients with these tests we recommend your review your charts and submit claims accordingly.

COVID-19 Treatment

There are effective treatment options available for COVID-19 that can help to reduce the risk of severe outcomes, such as hospitalization and death. However, treatments are very time-sensitive, and should be started by day three to five after symptom onset. 

Treatment options include monoclonal antibodies (Sotrovimab) and antivirals (Paxlovid), and patients in designated higher-risk groups are eligible. Patients must be diagnosed by a provider with COVID-19 using either a rapid test or PCR.
Key resources include:

Please note: This therapy is available via referral only, with central referral intake and review in each health region. Designated prescribers have similarly been established in each region to support this program, and ensure that the therapy is prescribed within established criteria given an extremely limited supply of Paxlovid initially.

At this time, supplies are limited for COVID-19 treatments, which means they are being centrally managed within each health region and accessible via referral only. 

If you have further questions, contact COVID therapeutics referral intake as follows:

Last updated
April 14, 2022